celecoxib has been researched along with Retinopathy of Prematurity in 1 studies
Retinopathy of Prematurity: A bilateral retinopathy occurring in premature infants treated with excessively high concentrations of oxygen, characterized by vascular dilatation, proliferation, and tortuosity, edema, and retinal detachment, with ultimate conversion of the retina into a fibrous mass that can be seen as a dense retrolental membrane. Usually growth of the eye is arrested and may result in microophthalmia, and blindness may occur. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib- treated OIR mice reduced the retinal neovascular tufts and the levels of VEGF and HIF-1α." | 1.42 | Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy. ( Cai, N; Chen, L; Liu, N, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, N | 1 |
| Chen, L | 1 |
| Cai, N | 1 |
1 other study available for celecoxib and Retinopathy of Prematurity
| Article | Year |
|---|---|
Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Celecoxib; Cyclooxygenase 2 Inhibitors; Disease | 2015 |